Gene Symbol | Gene ID | Gene Info |
---|---|---|
RARG
|
ENSG00000172819.12 | retinoic acid receptor gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_53610024_53610290 | RARG | 3886 | 0.131034 | -0.72 | 2.8e-02 | Click! |
chr12_53613957_53614108 | RARG | 11 | 0.958907 | -0.69 | 3.8e-02 | Click! |
chr12_53613530_53613749 | RARG | 404 | 0.746507 | -0.68 | 4.6e-02 | Click! |
chr12_53629931_53630180 | RARG | 3291 | 0.139813 | -0.67 | 5.0e-02 | Click! |
chr12_53615812_53616039 | RARG | 1728 | 0.225901 | -0.64 | 6.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr22_50356250_50357150 | 1.36 |
PIM3 |
pim-3 oncogene |
2539 |
0.27 |
chr19_4063421_4064204 | 1.31 |
CTD-2622I13.3 |
|
1065 |
0.34 |
chr17_19806867_19807136 | 1.22 |
RP11-209D14.4 |
|
26049 |
0.15 |
chr7_75592437_75593112 | 1.17 |
POR |
P450 (cytochrome) oxidoreductase |
4387 |
0.19 |
chr1_156675699_156676565 | 1.12 |
CRABP2 |
cellular retinoic acid binding protein 2 |
524 |
0.6 |
chr10_94831581_94832316 | 1.07 |
CYP26A1 |
cytochrome P450, family 26, subfamily A, polypeptide 1 |
1284 |
0.45 |
chr19_1513130_1513873 | 1.06 |
ADAMTSL5 |
ADAMTS-like 5 |
313 |
0.73 |
chr11_63743343_63744223 | 1.06 |
AP000721.4 |
Uncharacterized protein |
1691 |
0.2 |
chr15_75082253_75083502 | 1.00 |
ENSG00000264386 |
. |
1779 |
0.21 |
chr2_72175971_72176122 | 0.98 |
CYP26B1 |
cytochrome P450, family 26, subfamily B, polypeptide 1 |
194167 |
0.03 |
chr13_114428750_114429093 | 0.98 |
TMEM255B |
transmembrane protein 255B |
33295 |
0.18 |
chr1_2201758_2202172 | 0.98 |
SKI |
v-ski avian sarcoma viral oncogene homolog |
41831 |
0.09 |
chr3_122803672_122804475 | 0.98 |
PDIA5 |
protein disulfide isomerase family A, member 5 |
17878 |
0.23 |
chr11_63994452_63995293 | 0.97 |
NUDT22 |
nudix (nucleoside diphosphate linked moiety X)-type motif 22 |
791 |
0.28 |
chr15_74232933_74233272 | 0.92 |
LOXL1-AS1 |
LOXL1 antisense RNA 1 |
12513 |
0.14 |
chr19_1168901_1169806 | 0.92 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
411 |
0.76 |
chr17_17508776_17508930 | 0.90 |
PEMT |
phosphatidylethanolamine N-methyltransferase |
13831 |
0.15 |
chr19_3094776_3095602 | 0.87 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
781 |
0.49 |
chr16_88518586_88519370 | 0.84 |
ZFPM1 |
zinc finger protein, FOG family member 1 |
747 |
0.63 |
chr15_62737179_62737605 | 0.83 |
TLN2 |
talin 2 |
116172 |
0.06 |
chr6_82407498_82407649 | 0.82 |
RP5-991C6.4 |
|
38497 |
0.16 |
chr7_100859763_100860679 | 0.82 |
ZNHIT1 |
zinc finger, HIT-type containing 1 |
728 |
0.34 |
chr2_63991472_63991650 | 0.82 |
ENSG00000221085 |
. |
68892 |
0.11 |
chr1_66943315_66943466 | 0.80 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
55676 |
0.15 |
chr11_65343918_65345038 | 0.75 |
EHBP1L1 |
EH domain binding protein 1-like 1 |
961 |
0.3 |
chr2_216613985_216614378 | 0.75 |
ENSG00000212055 |
. |
129461 |
0.05 |
chr8_21494888_21495039 | 0.75 |
ENSG00000266630 |
. |
87454 |
0.09 |
chr1_844466_844723 | 0.75 |
SAMD11 |
sterile alpha motif domain containing 11 |
15666 |
0.11 |
chr1_17337199_17337799 | 0.74 |
ATP13A2 |
ATPase type 13A2 |
768 |
0.6 |
chr9_137118247_137118684 | 0.74 |
ENSG00000221676 |
. |
88779 |
0.07 |
chr17_47922415_47922772 | 0.74 |
RP11-304F15.3 |
|
679 |
0.63 |
chr14_52519431_52519582 | 0.74 |
NID2 |
nidogen 2 (osteonidogen) |
13836 |
0.2 |
chr12_6472663_6473337 | 0.73 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
313 |
0.83 |
chr2_238343817_238344489 | 0.72 |
AC112721.1 |
Uncharacterized protein |
10234 |
0.19 |
chr4_113437546_113438608 | 0.72 |
NEUROG2 |
neurogenin 2 |
749 |
0.58 |
chr22_44759775_44760116 | 0.72 |
RP1-32I10.10 |
Uncharacterized protein |
1486 |
0.51 |
chr5_139035453_139035988 | 0.72 |
CXXC5 |
CXXC finger protein 5 |
3420 |
0.27 |
chr17_48287279_48287648 | 0.71 |
COL1A1 |
collagen, type I, alpha 1 |
8470 |
0.12 |
chr15_67055010_67055873 | 0.71 |
SMAD6 |
SMAD family member 6 |
51406 |
0.15 |
chr6_33641254_33641439 | 0.71 |
SBP1 |
SBP1; Uncharacterized protein |
22128 |
0.12 |
chr19_1254241_1254773 | 0.71 |
MIDN |
midnolin |
2886 |
0.11 |
chr3_16166790_16167040 | 0.71 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
49241 |
0.16 |
chr16_70789200_70789351 | 0.70 |
VAC14-AS1 |
VAC14 antisense RNA 1 |
239 |
0.91 |
chr16_72928092_72928381 | 0.70 |
ENSG00000251868 |
. |
72345 |
0.09 |
chr17_48030175_48030326 | 0.69 |
ENSG00000199492 |
. |
13290 |
0.15 |
chr3_157185329_157185658 | 0.68 |
VEPH1 |
ventricular zone expressed PH domain-containing 1 |
27802 |
0.19 |
chr11_1146453_1147024 | 0.68 |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
4842 |
0.22 |
chr6_160457258_160457573 | 0.67 |
AIRN |
antisense of IGF2R non-protein coding RNA |
28719 |
0.19 |
chr3_45687605_45688015 | 0.67 |
LIMD1-AS1 |
LIMD1 antisense RNA 1 |
42564 |
0.12 |
chr5_133889727_133890225 | 0.67 |
JADE2 |
jade family PHD finger 2 |
27649 |
0.13 |
chr10_80916996_80917718 | 0.67 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
88565 |
0.09 |
chr5_57080261_57080412 | 0.67 |
ENSG00000266864 |
. |
88537 |
0.1 |
chr14_76457853_76458004 | 0.66 |
IFT43 |
intraflagellar transport 43 homolog (Chlamydomonas) |
5801 |
0.24 |
chr17_3892192_3892343 | 0.66 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
24531 |
0.15 |
chr9_84434747_84434898 | 0.66 |
ENSG00000263404 |
. |
13826 |
0.21 |
chr11_123390588_123390739 | 0.66 |
GRAMD1B |
GRAM domain containing 1B |
5681 |
0.27 |
chr1_1295387_1295783 | 0.66 |
MXRA8 |
matrix-remodelling associated 8 |
1572 |
0.16 |
chr17_49257331_49257482 | 0.66 |
NME1-NME2 |
NME1-NME2 readthrough |
13481 |
0.14 |
chr2_109895716_109896134 | 0.65 |
ENSG00000265965 |
. |
34156 |
0.23 |
chr16_73248418_73248569 | 0.65 |
C16orf47 |
chromosome 16 open reading frame 47 |
70147 |
0.13 |
chr14_105556862_105557293 | 0.64 |
GPR132 |
G protein-coupled receptor 132 |
25295 |
0.16 |
chr5_167740954_167741105 | 0.64 |
WWC1 |
WW and C2 domain containing 1 |
21874 |
0.23 |
chr17_40673744_40674238 | 0.64 |
ENSG00000265611 |
. |
7785 |
0.08 |
chr11_67138326_67138968 | 0.64 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
2561 |
0.12 |
chr11_65185776_65186435 | 0.64 |
ENSG00000245532 |
. |
25824 |
0.09 |
chr3_8499776_8500071 | 0.63 |
LMCD1-AS1 |
LMCD1 antisense RNA 1 (head to head) |
43361 |
0.15 |
chr10_81181755_81182122 | 0.63 |
ZCCHC24 |
zinc finger, CCHC domain containing 24 |
22037 |
0.18 |
chr1_7531258_7531628 | 0.63 |
RP4-549F15.1 |
|
29829 |
0.21 |
chr11_73110209_73110498 | 0.62 |
RP11-809N8.2 |
|
2872 |
0.21 |
chr17_79070617_79071314 | 0.62 |
BAIAP2 |
BAI1-associated protein 2 |
414 |
0.74 |
chr1_201595443_201595594 | 0.62 |
NAV1 |
neuron navigator 1 |
2917 |
0.21 |
chr21_47480957_47481280 | 0.62 |
AP001471.1 |
|
36326 |
0.12 |
chr8_145150393_145151259 | 0.62 |
CYC1 |
cytochrome c-1 |
896 |
0.32 |
chr6_151392661_151392812 | 0.61 |
RP1-292B18.3 |
|
15543 |
0.18 |
chr7_77827088_77827239 | 0.61 |
RP5-1185I7.1 |
|
207426 |
0.03 |
chr1_201605696_201605997 | 0.61 |
NAV1 |
neuron navigator 1 |
11531 |
0.15 |
chr19_56061421_56061707 | 0.61 |
SBK3 |
SH3 domain binding kinase family, member 3 |
4655 |
0.1 |
chr1_19217476_19217627 | 0.60 |
ALDH4A1 |
aldehyde dehydrogenase 4 family, member A1 |
166 |
0.94 |
chr12_288574_288860 | 0.60 |
RP11-598F7.5 |
|
13230 |
0.12 |
chr1_19753360_19753532 | 0.60 |
ENSG00000240490 |
. |
2568 |
0.24 |
chr2_118818295_118818470 | 0.60 |
INSIG2 |
insulin induced gene 2 |
27668 |
0.15 |
chr2_225667774_225667925 | 0.60 |
DOCK10 |
dedicator of cytokinesis 10 |
13520 |
0.31 |
chr12_92692622_92693037 | 0.59 |
RP11-693J15.4 |
|
122478 |
0.05 |
chr1_92020838_92021666 | 0.59 |
CDC7 |
cell division cycle 7 |
54557 |
0.17 |
chr9_91144416_91144843 | 0.59 |
NXNL2 |
nucleoredoxin-like 2 |
5387 |
0.32 |
chr5_150023934_150024085 | 0.59 |
SYNPO |
synaptopodin |
3769 |
0.18 |
chr1_201469880_201470164 | 0.59 |
CSRP1 |
cysteine and glycine-rich protein 1 |
4321 |
0.18 |
chr7_155600686_155601304 | 0.59 |
SHH |
sonic hedgehog |
771 |
0.71 |
chr22_36748127_36749442 | 0.59 |
MYH9 |
myosin, heavy chain 9, non-muscle |
12372 |
0.18 |
chr15_89738741_89738892 | 0.59 |
RLBP1 |
retinaldehyde binding protein 1 |
16258 |
0.19 |
chr11_9161140_9161485 | 0.58 |
DENND5A |
DENN/MADD domain containing 5A |
3687 |
0.23 |
chr6_43810237_43810388 | 0.58 |
VEGFA |
vascular endothelial growth factor A |
68222 |
0.09 |
chr20_62694983_62695936 | 0.58 |
TCEA2 |
transcription elongation factor A (SII), 2 |
19 |
0.95 |
chr17_17642775_17643230 | 0.58 |
RAI1-AS1 |
RAI1 antisense RNA 1 |
31133 |
0.12 |
chr19_1409918_1411040 | 0.58 |
DAZAP1 |
DAZ associated protein 1 |
2745 |
0.1 |
chr3_187984919_187985084 | 0.58 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
27349 |
0.24 |
chr17_79994361_79995124 | 0.58 |
DCXR |
dicarbonyl/L-xylulose reductase |
129 |
0.86 |
chr2_242501520_242501805 | 0.58 |
BOK-AS1 |
BOK antisense RNA 1 |
3270 |
0.16 |
chr5_179246518_179247261 | 0.57 |
SQSTM1 |
sequestosome 1 |
870 |
0.42 |
chr2_47056308_47056459 | 0.57 |
LINC01119 |
long intergenic non-protein coding RNA 1119 |
12547 |
0.15 |
chr3_159943799_159944583 | 0.57 |
RP11-431I8.1 |
|
79 |
0.91 |
chr1_14226713_14227012 | 0.57 |
PRDM2 |
PR domain containing 2, with ZNF domain |
128641 |
0.05 |
chr6_113253230_113253381 | 0.57 |
ENSG00000201386 |
. |
39390 |
0.23 |
chr6_42490380_42490672 | 0.57 |
ENSG00000238611 |
. |
17182 |
0.19 |
chr12_63125937_63126088 | 0.57 |
ENSG00000238475 |
. |
81057 |
0.09 |
chr12_125550229_125550908 | 0.57 |
AACS |
acetoacetyl-CoA synthetase |
581 |
0.82 |
chr3_183886938_183887238 | 0.57 |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit |
5389 |
0.11 |
chr15_48910566_48910870 | 0.56 |
FBN1 |
fibrillin 1 |
27200 |
0.23 |
chr1_9339326_9339860 | 0.56 |
ENSG00000252841 |
. |
1143 |
0.5 |
chr8_96815285_96815571 | 0.56 |
ENSG00000223297 |
. |
124285 |
0.06 |
chr5_36404993_36405144 | 0.56 |
ENSG00000222178 |
. |
80377 |
0.09 |
chr1_33766764_33766998 | 0.56 |
RP11-415J8.3 |
|
6086 |
0.14 |
chr1_54015548_54015831 | 0.56 |
DMRTB1 |
DMRT-like family B with proline-rich C-terminal, 1 |
90617 |
0.07 |
chr19_47524229_47524951 | 0.56 |
NPAS1 |
neuronal PAS domain protein 1 |
447 |
0.8 |
chr18_21302680_21302831 | 0.56 |
LAMA3 |
laminin, alpha 3 |
33107 |
0.18 |
chr1_1476104_1476623 | 0.55 |
TMEM240 |
transmembrane protein 240 |
530 |
0.63 |
chr11_10346579_10346730 | 0.55 |
AMPD3 |
adenosine monophosphate deaminase 3 |
7436 |
0.17 |
chr19_1361317_1362052 | 0.55 |
MUM1 |
melanoma associated antigen (mutated) 1 |
5321 |
0.1 |
chr20_30426135_30426437 | 0.55 |
FOXS1 |
forkhead box S1 |
7134 |
0.14 |
chr11_118782916_118784128 | 0.55 |
BCL9L |
B-cell CLL/lymphoma 9-like |
1909 |
0.16 |
chr9_16885120_16885444 | 0.55 |
BNC2 |
basonuclin 2 |
14441 |
0.29 |
chr3_134082413_134082992 | 0.55 |
AMOTL2 |
angiomotin like 2 |
8052 |
0.23 |
chr8_32623200_32623351 | 0.55 |
NRG1 |
neuregulin 1 |
43912 |
0.2 |
chr14_24017428_24017685 | 0.55 |
ZFHX2 |
zinc finger homeobox 2 |
107 |
0.93 |
chr20_19869740_19869891 | 0.55 |
RIN2 |
Ras and Rab interactor 2 |
395 |
0.9 |
chr17_48065039_48065349 | 0.55 |
DLX3 |
distal-less homeobox 3 |
5873 |
0.16 |
chr6_52385479_52385630 | 0.55 |
TRAM2 |
translocation associated membrane protein 2 |
56159 |
0.13 |
chr15_89545625_89545992 | 0.54 |
ENSG00000265866 |
. |
30125 |
0.17 |
chr11_587585_588264 | 0.54 |
PHRF1 |
PHD and ring finger domains 1 |
11403 |
0.07 |
chr8_37659341_37659694 | 0.54 |
GPR124 |
G protein-coupled receptor 124 |
4743 |
0.17 |
chr11_102015852_102016003 | 0.54 |
YAP1 |
Yes-associated protein 1 |
32682 |
0.14 |
chr15_71099407_71099754 | 0.54 |
RP11-138H8.3 |
|
28373 |
0.14 |
chr2_1576006_1576157 | 0.54 |
AC144450.1 |
|
47804 |
0.16 |
chr14_35853313_35853625 | 0.54 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
19877 |
0.23 |
chr10_13881950_13882101 | 0.54 |
FRMD4A |
FERM domain containing 4A |
18887 |
0.22 |
chr5_172327841_172328220 | 0.54 |
ERGIC1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
4190 |
0.22 |
chr1_17559878_17560367 | 0.54 |
PADI1 |
peptidyl arginine deiminase, type I |
272 |
0.9 |
chr14_100435117_100435268 | 0.53 |
EVL |
Enah/Vasp-like |
2594 |
0.28 |
chr3_99419845_99419996 | 0.53 |
ENSG00000263810 |
. |
9505 |
0.27 |
chr17_15175242_15175393 | 0.53 |
PMP22 |
peripheral myelin protein 22 |
6674 |
0.15 |
chr16_87206925_87207208 | 0.53 |
RP11-899L11.3 |
|
42455 |
0.16 |
chr5_133903473_133903869 | 0.53 |
JADE2 |
jade family PHD finger 2 |
41344 |
0.11 |
chr8_36999886_37000356 | 0.53 |
KCNU1 |
potassium channel, subfamily U, member 1 |
213698 |
0.02 |
chr5_150025102_150025253 | 0.53 |
SYNPO |
synaptopodin |
4937 |
0.16 |
chr7_93894375_93894526 | 0.53 |
COL1A2 |
collagen, type I, alpha 2 |
129423 |
0.05 |
chr8_144611605_144612253 | 0.53 |
ZC3H3 |
zinc finger CCCH-type containing 3 |
11694 |
0.08 |
chr11_8046300_8046451 | 0.53 |
TUB |
tubby bipartite transcription factor |
5584 |
0.14 |
chr12_89032380_89032588 | 0.53 |
ENSG00000252850 |
. |
57068 |
0.15 |
chr9_136821628_136822276 | 0.53 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
35451 |
0.17 |
chr11_114178834_114179221 | 0.53 |
NNMT |
nicotinamide N-methyltransferase |
10154 |
0.21 |
chr13_114895448_114896100 | 0.53 |
RASA3 |
RAS p21 protein activator 3 |
2253 |
0.34 |
chr5_148552879_148553157 | 0.52 |
ABLIM3 |
actin binding LIM protein family, member 3 |
31408 |
0.15 |
chr17_45372022_45372173 | 0.52 |
RP11-290H9.4 |
|
10954 |
0.14 |
chr4_7908880_7909182 | 0.52 |
AC097381.1 |
|
31697 |
0.17 |
chr13_108074025_108074176 | 0.52 |
ENSG00000201847 |
. |
100789 |
0.08 |
chr17_2084323_2084474 | 0.52 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
7926 |
0.13 |
chr10_81168464_81168615 | 0.52 |
RP11-342M3.5 |
|
26455 |
0.17 |
chr12_3405574_3405725 | 0.52 |
PRMT8 |
protein arginine methyltransferase 8 |
84866 |
0.09 |
chr10_82233583_82234488 | 0.52 |
TSPAN14 |
tetraspanin 14 |
14977 |
0.2 |
chr5_172305112_172305469 | 0.52 |
ERGIC1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
26930 |
0.16 |
chr4_160319643_160319794 | 0.52 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
48338 |
0.17 |
chr6_169474932_169475083 | 0.52 |
XXyac-YX65C7_A.2 |
|
138342 |
0.05 |
chr8_12985135_12985435 | 0.52 |
DLC1 |
deleted in liver cancer 1 |
5698 |
0.25 |
chr9_33159298_33160222 | 0.52 |
RP11-326F20.5 |
|
7213 |
0.15 |
chr12_115272734_115272885 | 0.52 |
ENSG00000252459 |
. |
97300 |
0.08 |
chr17_19273582_19274475 | 0.52 |
MAPK7 |
mitogen-activated protein kinase 7 |
7006 |
0.11 |
chr17_26673430_26673700 | 0.51 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
6133 |
0.07 |
chr16_15884356_15884507 | 0.51 |
AF001548.6 |
|
49423 |
0.1 |
chr16_78177169_78177320 | 0.51 |
WWOX |
WW domain containing oxidoreductase |
43653 |
0.17 |
chr7_139360055_139360612 | 0.51 |
HIPK2 |
homeodomain interacting protein kinase 2 |
61508 |
0.13 |
chr19_35630229_35630677 | 0.51 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
108 |
0.92 |
chr1_21644746_21645038 | 0.51 |
ECE1 |
endothelin converting enzyme 1 |
19400 |
0.18 |
chr11_101312498_101312720 | 0.51 |
ENSG00000263885 |
. |
78027 |
0.11 |
chr2_10417901_10418493 | 0.51 |
ENSG00000264030 |
. |
2560 |
0.25 |
chr2_97274281_97274432 | 0.51 |
KANSL3 |
KAT8 regulatory NSL complex subunit 3 |
29690 |
0.17 |
chr10_134755869_134756456 | 0.51 |
TTC40 |
tetratricopeptide repeat domain 40 |
73 |
0.98 |
chr20_60878742_60879796 | 0.51 |
ADRM1 |
adhesion regulating molecule 1 |
1208 |
0.33 |
chr3_66444911_66445177 | 0.51 |
ENSG00000241587 |
. |
70765 |
0.12 |
chr3_148722415_148722820 | 0.51 |
GYG1 |
glycogenin 1 |
12459 |
0.19 |
chr15_68785532_68785683 | 0.51 |
ITGA11 |
integrin, alpha 11 |
61106 |
0.13 |
chr11_130348758_130348944 | 0.50 |
ADAMTS15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
29982 |
0.21 |
chr8_134165036_134165303 | 0.50 |
WISP1 |
WNT1 inducible signaling pathway protein 1 |
38113 |
0.15 |
chr14_55120909_55121243 | 0.50 |
SAMD4A |
sterile alpha motif domain containing 4A |
86439 |
0.09 |
chr19_18950225_18950475 | 0.50 |
UPF1 |
UPF1 regulator of nonsense transcripts homolog (yeast) |
7540 |
0.14 |
chr9_34253979_34254272 | 0.50 |
ENSG00000222426 |
. |
28543 |
0.11 |
chr15_80466917_80467209 | 0.50 |
FAH |
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
18770 |
0.21 |
chr13_114833656_114834155 | 0.50 |
RASA3 |
RAS p21 protein activator 3 |
9533 |
0.25 |
chr10_114523488_114523639 | 0.50 |
RP11-57H14.4 |
|
59686 |
0.13 |
chr20_62600239_62600795 | 0.50 |
ZNF512B |
zinc finger protein 512B |
701 |
0.44 |
chr22_46489010_46489303 | 0.50 |
ENSG00000266533 |
. |
2232 |
0.16 |
chr15_89662134_89662365 | 0.50 |
ENSG00000239151 |
. |
1761 |
0.34 |
chr19_980614_980765 | 0.50 |
WDR18 |
WD repeat domain 18 |
3642 |
0.1 |
chr12_53611123_53611600 | 0.50 |
RARG |
retinoic acid receptor, gamma |
2682 |
0.16 |
chr12_1689271_1689422 | 0.50 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
5523 |
0.23 |
chr5_141805717_141806067 | 0.50 |
AC005592.2 |
|
22109 |
0.24 |
chr10_634354_634505 | 0.50 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
4529 |
0.22 |
chr1_26347781_26347932 | 0.50 |
EXTL1 |
exostosin-like glycosyltransferase 1 |
415 |
0.72 |
chr1_159750946_159751524 | 0.50 |
DUSP23 |
dual specificity phosphatase 23 |
442 |
0.77 |
chr22_39181429_39181714 | 0.49 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
8577 |
0.1 |
chr19_17187794_17188874 | 0.49 |
MYO9B |
myosin IXB |
1738 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 1.2 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 1.0 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 1.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.3 | 0.8 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.9 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.2 | 0.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.2 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.2 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.6 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.2 | 2.4 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.2 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.5 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.6 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 1.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.6 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.4 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.4 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 0.5 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0090190 | ureteric bud formation(GO:0060676) positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 2.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.4 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 1.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 2.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.2 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0019368 | fatty acid elongation, unsaturated fatty acid(GO:0019368) |
0.1 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.7 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.1 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.2 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.1 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0060180 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.1 | 0.4 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.2 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.1 | GO:1903391 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) regulation of adherens junction organization(GO:1903391) |
0.1 | 0.2 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.2 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.7 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.1 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 2.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 0.2 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.4 | GO:0090280 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.2 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.3 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.3 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0002913 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0060231 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) mesenchymal to epithelial transition(GO:0060231) renal vesicle development(GO:0072087) metanephric renal vesicle morphogenesis(GO:0072283) |
0.0 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.4 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.1 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 1.8 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0048668 | collateral sprouting(GO:0048668) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.1 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.7 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.1 | GO:0044058 | regulation of digestive system process(GO:0044058) |
0.0 | 0.1 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 1.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.2 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.5 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.3 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.5 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0060298 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.1 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.4 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.0 | 0.0 | GO:0048512 | circadian behavior(GO:0048512) |
0.0 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 0.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.7 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 1.6 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 3.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 9.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 2.8 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 12.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 2.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 2.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 2.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 2.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 1.4 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 1.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 2.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 4.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.9 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.5 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 5.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.9 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0046980 | tapasin binding(GO:0046980) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.4 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 1.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 2.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0005024 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0016775 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 2.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 6.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 10.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 3.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 7.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 2.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |